medical cannabis solutions HEALTHCARE PROFESSIONALS GUIDE

Similar documents
Use of Cannabinoids in Medical Practice

EMERGENCE OF CANNABIDIOL IN MEDICINE

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer

POLICY NUMBER: POL 153

Medicinal Cannabis. Patient Log Book. Record your cannabis use and find the right dose

Medical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

Consumer Information Cannabis (Marihuana, marijuana)

Dr. Meldon Kahan. Women s College Hospital. with PIA LAW

Medical Cannabis use in the Older Patient

Cannabinoids: access and symptom management in cancer

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

LGP CLASSIC Oil Products

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine

Reefer Madness version 3.0*

Medical Marijuana Consent Form

Medical vs Recreational Use of Cannabis. 11 th December 2017

Medical Marijuana: The Move to Schedule II

Smoking Cessation Pharmacotherapy Guidelines

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Important Information

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil?

INITIAL PATIENT INTAKE FORM

Medical Cannabis MATT WEBSTER DO, MS

Clinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD

Marijuana and the Workplace : Changing Times

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

CANNABIS AND PAIN. Debra Kimless, M.D. Medical Director, ForwardGro MAOP Annual Meeting September 14, 2018

Faculty/Presenter Disclosure

Medical Marijuana Update Chris Belletieri, DO

A look at Marijuana in 2014

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

Medical Cannabis & Seniors - 101

Act 16 and Medical Cannabis in Pennsylvania

History Of Medical Cannabis

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Cannabis for Medical Purposes

Welcome to MedWell. Patient Information. Name: Address: City: State: Zip Code: !Other. Name: Address: City: State:

Treating Pain and Depression

Medical Marijuana: Hype versus Evidence

The Highs and Lows of Medical Marijuana

Substances under Surveillance

CBD and Your Health.

Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE

CANNABIS FOR THE RHEUMATOLOGIST

Petitions to Add Qualifying Medical Conditions to the Medical Cannabis Program A REPORT TO THE COMMISSIONER OF HEALTH

Guidance for the use of. medicinal cannabis. in Australia. Patient information

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

Medical Cannabis: A Patient Primer

Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Northern California Chapter, ACP Update In Medicine

Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

EMERGING ISSUES IN SMOKING CESSATION

GENERAL PRACTITIONER (GP) SUPPORT PACK

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

Prescription Opioid Addiction

Knock Out Opioid Abuse in New Jersey:

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Australian Medicinal Cannabis Pricing Analysis

This is a duplicated text of a letter from GW Pharma Ltd. Contact the company for a copy of any references, attachments or enclosures.

Drug Interactions Year 2 Clinical Pharmacology

Important Information

Use of Medical Marijuana in Cancer Treatment & Care

PATIENT QUESTIONNAIRE

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

Medical Cannabinoids for the Management of Chronic Noncancer Pain

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

CORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/ January 2013

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2

Recent trends in medical cannabis use in Canada

Scottsdale Certification Center Health History Questionnaire. Name Gender M / F Date. Date of Birth / / Phone Ht: ft in Wt. Residential Address

Susan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice

Understanding Hemp Extracts and CBD Oil. Quality assurance, product selection, and serving size tracking.

Budding Therapies: Medical Cannabis and its Uses

Marijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine

The Shifting Federal Regulation of Cannabis Products

ESCA: Cinacalcet (Mimpara )

History of Medical Cannabis in Nursing

Medicinal cannabis use among PLWH in the era of legalization

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

Gabapentin and pregabalin

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)

39 th Expert Committee on Drug Dependence Process and recommendations

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD

Transcription:

medical cannabis solutions HEALTHCARE PROFESSIONALS GUIDE support@naturalcaregroup.com 1.888.671.8022 N A T U R A L C A R E G R O U P. C O M

inside What s Working with Natural Care 2 How Natural Care works for patients 5 How Natural Care works in senior care 7 Prescribing and administering medical cannabis 9 Why medical cannabis? 16

Working with Natural Care It s simple: we re here to improve your patients or residents quality of life, and to lighten your workload. We create personalized cannabis plans. Whether you prescribe medical cannabis or refer to a Natural Care prescriber, we ll incorporate your recommendations into a personalized patient plan that includes a careful dosing and titration schedule. We ll follow up with regular calls to your patient, resident or their caregiver to ensure everything s on track. We offer ongoing, on-demand support. Our nurses and educators are on call to answer your questions. Your patients, residents and their caregivers can also call us directly for help with their personalized cannabis plans, licensed producer registration, orders, refills and more. NATURALCAREGROUP.COM 2

first We put patients We recommend the most suitable products for individual patients. We are completely licensed producer-agnostic. We provide up-to-date cannabis education. The Natural Care advantage starts with education: we offer comprehensive cannabis education for doctors, nurses and healthcare providers; we also conduct sessions at retirement and long-term care homes, community groups and more. We are experts in senior care and cannabis. Our team combines decades of retirement and longterm care management experience with seniorspecific healthcare expertise and medical cannabis savvy. We work directly with retirement and long-term care homes. We provide customized education sessions, as well as policy and administrative support. We make managing medical cannabis easy for homes and staff. We don t charge for our services. No matter how complex your patients or residents needs, our comprehensive services are always free. NATURALCAREGROUP.COM 4

How Natural Care works for patients We guide patients through every step of the prescription, registration, ordering and refill process. ASSESS PRESCRIBE PERSONALIZE REGISTER ORDER SUPPORT Meet with a nurse practitioner or doctor in person or online. If medical cannabis is suitable, the patient s MD or a Natural Care MD or NP generates a prescription. Based on the prescription notes, a Natural Care nurse creates an individualized cannabis medication plan. Based on the cannabis medication plan, Natural Care completes registration with the most suitable licensed producer(s). Natural Care s patient care team offers guidance throughout the ordering and refill process. Natural Care provides ongoing support for the life of every prescription. NATURALCAREGROUP.COM 6

Provide medical cannabis prescriptions How Natural Care works in senior care Medical cannabis and its legal bureaucracy can be complicated. WE MAKE IT SEAMLESS. Every home is different, and we work quickly to implement a customized medical cannabis program designed to improve residents quality of life and lighten staff workload. From training to policy implementation, medical administration, documentation and more, we ve got it covered. Update home and residence policies and procedures as needed Provide ondemand phone and email support to staff, residents, families and caregivers NATURAL CARE S COMPLIMENTARY SERVICES Provide ongoing education with staff, residents, families and caregivers Create personalized cannabis medication plans Complete patients LP registration NATURALCAREGROUP.COM 8

fast Prescribing and facts administering medical cannabis The rules and best practices around medical cannabis are just like other prescribed drugs. Potential medical benefits Likely beneficial for Potential side effects CBD Cannabidiol only Analgesic Anti-inflammatory Antiemetic Antispasmodic Anti-epileptic Anxiolytic Reduces THC-induced psychoactivity/anxiety Anxiety Depression Chronic pain Spasticity associated with MS, ALS and spinal cord injury Epilepsy Inflammation & inflammatory conditions, including IBS, ulcerative colitis, Crohn s, fibromyalgia, rheumatoid arthritis PTSD Cannabidiol exhibits biphasic properties most therapeutic effects are found at lower doses; slow titration may mitigate potential side effects. Somnolence, changes in appetite/weight In rare cases, may cause diarrhea CBD:THC Cannabidiol and tetrahydrocannabinol blends Analgesic Anti-inflammatory Antispasmodic Antiemetic Appetite stimulant Soporific Mood elevator Decreases intestinal motility Chronic pain Nausea & vomiting Anorexia Spasticity associated with MS, ALS and spinal cord injury Inflammation & inflammatory conditions, including IBS, ulcerative colitis, Crohn s, fibromyalgia, rheumatoid arthritis Limited evidence suggests that THC in particular may be beneficial for insomnia, neuropathic pain, nausea/vomiting and PTSD. It is recommended to start with CBD and introduce 1:1 in the evenings if needed for insomnia, PTSD, etc. Tetrahydrocannabinol exhibits biphasic properties most therapeutic effects are found at lower doses; slow titration may mitigate potential side effects. Anxiety, disorientation, intoxication, somnolence May induce psychosis in susceptible individuals (personal or family history) In rare cases, may cause orthostatic hypotension, depression, ataxia/ dyscoordination, tachycardia, cannabis hyperemesis, diarrhea NATURALCAREGROUP.COM 10

Contraindications Drug interactions CBD Cannabidiol only Unsuitable for pregnant and breastfeeding patients Many interactions can be mitigated in complex patients with polypharmacy by slowly titrating. CYP450 enzyme inhibitor May interact with anti-epileptic drugs; close monitoring of AED levels and LFTs advised Potent inhibitor of CYP3A4 and CYP2D6; may increase serum concentrations of macrolides, calcium channel blockers, benzodiazepines, cyclosporine, sildenafil (and other PDE5 inhibitors), antihistamines, haloperidol, antiretrovirals, and some statins (atorvastatin and simvastatin, but not pravastatin or rosuvastatin); may increase serum concentrations of SSRIs, tricyclic antidepressants, antipsychotics, beta blockers and opioids (including codeine and oxycodone) CBD:THC Cannabidiol and tetrahydrocannabinol blends Acute psychosis, severe/unstable psychiatric conditions, actively suicidal History of THC-induced hyperemesis Under age 25 Severe cardiovascular, immunological, liver or kidney disease (especially in acute illness can exacerbate arrhythmias) Caution should be exercised in patients with history of drug or alcohol addiction (although recent evidence points to cannabis as potential harm reduction substitution) Unsuitable for pregnant and breastfeeding patients Many interactions can be mitigated in complex patients with polypharmacy by slowly titrating. CYP450 enzyme inhibitor CYP1A2 inducer (theoretically can decrease serum concentrations of clozapine, duloxetine, naproxen, cyclobenzaprine, olanzapine, haloperidol, and chlorpromazine) Potential interaction with medications metabolized by P450 enzymes (2C9, 2C19, 3A4), including antidepressants, proton pump inhibitors, cimetidine, macrolides, antimycotics, calcium antagonists, HIV protease inhibitors, amiodarone, isoniazid The following drugs may decrease the availability of THC: carbamazepine, rifampicin, phenobarbital, phenytoin, primidone, rifabutin, St. John s wort Safety No reports of abuse or dependence; no public health risk. Minimal risk of dependence, similar to anxyolitics at 9%. (Versus 21% for opioids, 23% for alcohol and 68% for tobacco.) Dosing Oils & capsules/softgels Daytime dosing, non-intoxicating Daily dosing Start at 8-10mg/day Titrate by 5 mg as tolerated *Unless you wish otherwise, a Natural Care nurse will create a personalized dosing and titration schedule for every patient, with regular telephone check-ins and follow-up, at no charge. Oils & capsules/softgels Nighttime dosing, mild psychoactive, sedating effects At hs only to start Start at 2.5 mg, titrate by 1mg q 2-3 days as tolerated and to desired effect *Unless you wish otherwise, a Natural Care nurse will create a personalized dosing and titration schedule for every patient, with regular telephone check-ins and follow-up, at no charge. NATURALCAREGROUP.COM 12

Onset and duration of effects INHALATION ORAL INGESTION Product Flower Oils, capsules, softgels Onset Less than 5 min 30 min to 2 hrs Peak effect Less than 15 min 2 to 4 hrs Duration 2 to 4 hrs 4 to 8 hrs Notes Driving after cannabis use Ingestion methods are generally preferred for consistent dosing and longer impact. Some patients may desire inhalation for acute and breakout pain. Vapourizing recommended (not smoking). Patients should be counselled not to drive for 4 hours after inhalation, or for 8 hours if euphoria is experienced. Oils Administered sublingually, swallowed or mixed with food. Capsules & softgels Ingested as usual. Patients should be counselled not to drive for 6 hours after ingestion, or for 8 hours if euphoria is experienced. NATURALCAREGROUP.COM 14

Cannabis treats so many symptoms and conditions that a single cannabis prescription may reduce total prescription load. why cannabis? According to the Canadian Institute for Health Information, nearly a quarter of Canadians 65 and up take 10 or more prescription drugs: Seniors who were prescribed 10+ drugs were more likely to be hospitalized for an adverse drug reaction over five times more likely than seniors who were prescribed fewer drugs. 1 medical N A T U R A L C A R E G R O U P. C O M 16

Why medical cannabis? Medical cannabis patients report significant pain relief. In an observational study of over 2700 medical cannabis patients, conducted over three years at a nursing home in Israel 2, 93.7 % of respondents reported an improvement in their condition after six months. On a scale of one to 10, reported pain levels decreased from a median of eight to a median of four, representing a 50% REDUCTION IN PAIN. A cannabis prescription can significantly reduce opioid reliance, sometimes replacing opioid drugs entirely. Medical cannabis is safe. Fatal cannabis overdose is impossible. 4 The results of the Israel nursing home study were published in The European Journal of Internal Medicine. 5 Conclusion: Our study finds that the therapeutic use of cannabis is safe and efficacious in the elderly population. s F E a 18.1% of older adult patients stopped using opioid analgesics or reduced their dose after six months. 3 it's NATURALCAREGROUP.COM 18

Cannabis use is associated with better quality of life in patients with chronic pain. 6 Get your life back In a 2016 retrospective study of chronic pain patients, published in The Clinical Journal of Pain, researchers found a clinically significant association between cannabis use and better quality of life, as well as reduced opioid use and a better side effect profile when compared with opioid drugs. 7 A National Academies review also found that cannabis has a clinically meaningful effect on pain. 8 Cannabis treatment in agitated patients may reduce caregiver burnout. In a 14-week trial of Alzheimer s patients treated with the synthetic cannabinoid nabilone 9, Sunnybrook Hospital researchers found significantly reduced agitation compared with a placebo group and significantly improved behavioural symptoms overall. Researchers also found that this reduced patient agitation and aggression was associated with a clinically meaningful reduction in caregiver stress. NATURALCAREGROUP.COM 20

Contact us Join the growing number of healthcare professionals referring to Natural Care. Your patients and residents will thank you! J i o N us No matter how complex your patients or residents needs, our comprehensive services are always free. Email us at: support@naturalcaregroup.com Call us at: 1.888.671.8022 to learn more DOWNLOAD REFERRAL FORMS Please visit naturalcaregroup.com/forms to download new forms, or call or email us and we ll send some your way. NATURALCAREGROUP.COM 22

FOOTNOTES 1. The Canadian Institute for Health Information. May 17, 2018. 1 in 4 Canadian seniors prescribed 10 or more drugs. Available online at: https://www.cihi.ca/en/1-in-4-canadian-seniors-isprescribed-10-or-more-drugs 2. Abuhasira R et al. 2018. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly, European Journal of Internal Medicine. Available online at: https://www.ncbi.nlm. nih.gov/pubmed/29398248 3. Ibid 4. To date, there has never been a recorded death from ingesting too much cannabis. It is estimated that a fatal dose of marijuana would require the (physically impossible) ingestion of fifteen hundred pounds in fifteen minutes, according to David Schmader, author of Weed: The User s Guide and published at www.businessinsider.com/can-marijuana-kill-you-2016-11. 5. Abuhasira R et al. 2018. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine. Available online at: https://www.ncbi.nlm. nih.gov/pubmed/29398248 6. Bellnier T et al. 2018.Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. Mental Health Clinician. Available online at: http://mhc.cpnp.org/doi/10.9740/mhc.2018.05.110 Elliott DA, et al. 2016. Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy. Supportive Care in Cancer. Available online at: https://www. ncbi.nlm.nih.gov/pubmed/27005465 Fiz J et al. 2011. Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS One. Available online at: https://www.ncbi.nlm.nih.gov/ pubmed/21533029 Haroutounian S et al. 2016. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study. The Clinical Journal of Pain. Available online at: https://www.ncbi.nlm.nih.gov/pubmed/26889611 National Academies of Sciences, Engineering, and Medicine. 2017. The health effects of cannabis and cannabinoids: Current state of evidence and recommendations for research. The National Academies Press. Available online at: http://nationalacademies.org/hmd/ reports/2017/health-effects-of-cannabis-and-cannabinoids.aspx 7. Haroutounian S et al. 2016. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study. The Clinical Journal of Pain. Available online at: https://www.ncbi.nlm.nih.gov/pubmed/26889611 8. National Academies of Sciences, Engineering, and Medicine. 2017. The health effects of cannabis and cannabinoids: Current state of evidence and recommendations for research. The National Academies Press. Available online at: http://nationalacademies.org/hmd/ reports/2017/health-effects-of-cannabis-and-cannabinoids.aspx 9. Funded by The Alzheimer s Drug Discovery Foundation, the trial was conducted at Sunnybrook Hospital using the synthetic cannabinoid nabilone. Researchers noted that although it is too soon to extend the results to medical cannabis, the results are nevertheless promising. Learn more from the study s authors here: http://alzheimersocietyblog.ca/clearing-the-airabout-cannabis-and-dementia/ and here http://health.sunnybrook.ca/alzheimers/alzheimerspatients-agitation-cannabinoids This information is not intended to be a substitute for the advice of a healthcare professional nor a recommendation of any particular treatment regimen. Please consult with your healthcare practioners for professional advice pertaining to your particular condition. NATURALCAREGROUP.COM

support@naturalcaregroup.com 1.888.671.8022 N A T U R A L C A R E G R O U P. C O M